Spotlight on: skin care innovation of Dr. Joel Schlessinger

Throughout my career, I have continued to look for ways to offer more and better ways for people to have healthy, younger looking skin. That includes conducting more than 250 clinical trials. A clinical trial is a carefully structured research project, where innovations are tested to see how well they perform.

Dr. Joel Schlessinger and the unparalleled Advanced Skin Research Center

To conduct these trials, I created the Advanced Skin Research Center, which is a dermatology research center that provides data to pharmaceutical companies. Our trials are always conducted professionally and efficiently.

At any one time, up to 25 clinical studies may be taking place in our clinic, which is more than Creighton University and the University of Nebraska Dermatology departments do – combined.

The facility is 11,000 square feet, with seven full-time nurses managing the studies. Plus, there is a full-time physician assistant who helps with them. Our center has unmatched success metrics for:

  • Quickly completing study enrollments
  • Having high enrollment in most studies

Find out more if you’re interested in being part of one of the clinical studies currently overseen by Dr. Joel Schlessinger.

More details about a clinical study where Dr. Joel Schlessinger was the lead author of the report:

In a double-blind, placebo-controlled trial that took place in multiple centers, we compared Botox (made by Allergan) and Dysport (made by Medicis). Ultimately, Dysport provided faster results. Reduction of wrinkles and fine lines occurred as quickly as 24 hours, post-injection, with an average improvement time of two to four days.

Find more specifics in the Dr. Joel Schlessinger-led report, Dermatologic Surgery.

Posted Thursday, December 15th, 2011 at 2:31 am
Filed Under Category: Skin Care Innovation
You can leave a response, or trackback from your own site.


Leave a Reply